Delivery Order SPE2DE21D7020-SPE2D625F1TB1
- Not listed
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $55,947.15 by the Defense Health Agency's Medical Supply Chain on July 29, 2025, with an ultimate completion date of August 5, 2025. The contract, which carries no set-aside designation, calls for the delivery of Ranger Global DCB (drug-coated balloon) devices measuring 4.0 x 120mm with a 150cm length. Performance will take place at Boston...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order contract valued at $1,974.29 by the Defense Health Agency's Medical Supply Chain on July 2, 2025, with an ultimate completion date of July 10, 2025. The contract, issued without a set-aside designation, covers the procurement of a Ranger Global DCB (drug-coated balloon) OTW (over-the-wire) 7.0 x 60mm 80cm medical device. The contract employs fixed-price...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $5,710.95 to Boston Scientific Corp for Ranger Global drug-coated balloon (DCB) devices measuring 5.0 x 200mm with a 90cm length. This fixed-price contract with economic price adjustment provisions was awarded on September 19, 2025, with an ultimate completion date of September 26, 2025. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts, and no small business set-aside was...
- This delivery order, valued at $5,214.96, was awarded to Boston Scientific Corp on July 29, 2025, for the supply of Ranger Global DCB (drug-coated balloon) OTW (over-the-wire) devices measuring 5.0 x 200mm with a 150cm length. The contract is funded through the Defense Health Agency's Medical Supply Chain division and employs fixed-price pricing with economic price adjustment terms. Performance will occur at Boston Scientific's facility in Marlborough, Massachusetts, with an ultimate...
- Boston Scientific Corp has been awarded a delivery order valued at $1,974.29 by the Defense Health Agency's Medical Supply Chain for the procurement of Ranger Global DCB OTW 6.0 x 100mm 135cm medical devices. The contract utilizes a fixed-price pricing structure with economic price adjustment provisions and carries an ultimate completion date of September 22, 2025. The award was made without a set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace....
- Boston Scientific Corp has been awarded a delivery order by the Defense Health Agency's Medical Supply Chain for RANGER GLOBAL DCB OTW 4.0 x 120MM 150CM medical devices, with a ceiling value of $30,554.50 under a fixed-price contract with economic price adjustment provisions. The award was made on August 4, 2025, with an ultimate completion date of August 11, 2025. This is an open competition contract with no set-aside designation, and the place of performance is Boston Scientific's facility...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $10,349.06 by the Defense Health Agency's Medical Supply Chain for RANGER GLOBAL DCB OTW 7.0 X 120MM 150CM medical devices. The contract, awarded on September 11, 2025, with an ultimate completion date of September 18, 2025, utilizes fixed-price pricing with economic price adjustment and was not set aside for any specific business type. The place of...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $7,074.77 by the Defense Health Agency's Medical Supply Chain for a Ranger Global DCB OTW 6.0 x 40mm 135cm medical device. The contract is a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of September 19, 2025. This award represents a competitive procurement with no set-aside designation,...
- Boston Scientific Corp has been awarded a delivery order valued at $14,898.01 for a Ranger Global DCB OTW 4.0 x 60mm catheter system with a 135cm length, with an ultimate completion date of September 16, 2025. The contract is a fixed-price agreement with economic price adjustment provisions and was awarded on September 9, 2025 without set-aside restrictions. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts, and is funded through the Defense Health Agency's...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $18,134.55 for agent drug-coated balloons by the Defense Health Agency's Medical Supply Chain on August 8, 2025. The delivery order, which carries an ultimate completion date of August 15, 2025, represents a competitive award with no set-aside designation. The contract employs fixed-price pricing with economic price adjustment mechanisms...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F1TB1Delivery Order
Boston Scientific Corp was awarded a $26,303.48 fixed-price delivery order with economic price adjustment by the Defense Health Agency's Medical Supply Chain on June 10, 2025, for the supply of Ranger Global DCB (Drug-Coated Balloon) orthopedic/thoracic wound care products (7.0 x 200mm, 150cm). The contract is not set-aside and calls for completion by June 17, 2025, with performance taking place at Boston Scientific's facility in Marlborough, Massachusetts. This delivery order represents a tactical procurement under the company's existing relationship with the Defense Health Agency, which has previously awarded Boston Scientific multiple contracts for specialized medical devices and cardiovascular intervention technologies. As a leading global medical technology company, Boston Scientific maintains a substantial federal portfolio serving healthcare agencies including the Department of Veterans Affairs and Defense Logistics Agency. The company's federal contracting history demonstrates extensive capability in providing advanced medical devices such as stents, pacemakers, cardiac resynchronization therapy systems, and neurostimulation equipment. This particular delivery order underscores Boston Scientific's role as a critical supplier of interventional medical technologies to the federal healthcare system, enabling the Defense Health Agency to maintain its supply chain of specialized medical devices necessary for patient care across military and defense healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.3k | 6/10/25 |